Skip to main content

Equibles does not estimate personal net worth.

About Mark Litton

Mark Litton is recorded as CEO at LeonaBio, Inc. (LONA) since October 18, 2021, Board Member at LeonaBio, Inc. (LONA) since January 1, 2021 and COO at LeonaBio, Inc. (LONA). The newest filing on record that lists Mark Litton as Board Member at LeonaBio, Inc. (LONA) is dated May 11, 2026. The newest filing on record that lists Mark Litton as COO at LeonaBio, Inc. (LONA) is dated April 16, 2021. The proxy statement of LeonaBio, Inc. reports total compensation of $1,423,814 for Mark Litton in fiscal 2025, including a base salary of $625,000. Disclosed compensation is on record for 5 fiscal years. LeonaBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LeonaBio, Inc. includes Andrew Gengos (CFO), Robert Renninger (CFO and Chief Accounting Officer), Mark Worthington (General Counsel) and 7 others.

Affiliation history

Company network

Current role

Biotechnology · Healthcare

COO, CEO, Board Member

2021-01-01–present

Leadership on record at LeonaBio, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 LeonaBio, Inc. (LONA) $625,000 $1,423,814
2024 LeonaBio, Inc. (LONA) $625,000 $3,175,009
2023 LeonaBio, Inc. (LONA) $585,000 $2,276,537
2022 LeonaBio, Inc. (LONA) $543,400 $3,775,199
2021 LeonaBio, Inc. (LONA) $450,000 $2,954,689

Recent activity

No call appearances or filed executive changes recorded yet.